Brazil Epigenetics Market Size & Outlook, 2023-2030
Brazil epigenetics market, 2018-2030 (US$M)
Related Markets
Brazil epigenetics market highlights
- The Brazil epigenetics market generated a revenue of USD 271.0 million in 2023 and is expected to reach USD 669.1 million by 2030.
- The Brazil market is expected to grow at a CAGR of 13.8% from 2024 to 2030.
- In terms of segment, reagents was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Epigenetics market data book summary
| Market revenue in 2023 | USD 271.0 million |
| Market revenue in 2030 | USD 669.1 million |
| Growth rate | 13.8% (CAGR from 2023 to 2030) |
| Largest segment | Reagents |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents, Kits, Instruments, Enzymes, Services |
| Key market players worldwide | Roche Holding AG, Thermo Fisher Scientific Inc, Eisai Co Ltd, Novartis AG ADR, Element Biosciences, Dovetail Genomics, Illumina Inc, Promega, Abcam PLC |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.9% of the global epigenetics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil epigenetics market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 669.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Epigenetics Market Scope
Epigenetics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil epigenetics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to epigenetics market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 32.8% in 2023. Horizon Databook has segmented the Brazil epigenetics market based on reagents, kits, instruments, enzymes, services covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil has a robust healthcare sector, ranking 14th globally in terms of healthcare expenditure. This creates a receptive environment for epigenetics-based applications in diagnostics, therapeutics, and research. Brazil has a growing network of research institutions and universities exploring epigenetics applications in various fields.
For instance, in July 2022, Geneseeq collaborated with Hospital de Base in Sao José do Rio Preto, Brazil, to establish an in-house Next-Generation Sequencing (NGS)-based precision oncology lab. This partnership aims to advance clinical research and provide comprehensive genetic testing to cancer patients in Brazil.
While the focus is on genomics, the collaboration indirectly contributes to the broader genetic research landscape, including epigenetics-related aspects. Furthermore, the Brazilian government actively supports R&D in biotechnology through numerous institutions, such as ApexBrasil, Abiquifi, Embrapa, and the National Council for Scientific & Technological Development (CNPq).
Reasons to subscribe to Brazil epigenetics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil epigenetics market databook
-
Our clientele includes a mix of epigenetics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil epigenetics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil epigenetics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil epigenetics market size, by product, 2018-2030 (US$M)
Brazil Epigenetics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
